Carbohydrates and Chronic Kidney Disease

Childhood Acute Kidney Injury In ICU Raises Risk Of Chronic Kidney Disease

medicalnewstoday.com — “According to a study published in the April issue of the American Journal of Kidney Diseases, children are more likely to develop chronic kidney disease (CKD) if they have suffered and reco” View full resource at medicalnewstoday.com

Most Recently Shared on April 5, 2012 at 9:05 pm By:

MNT Pediatrics News Pediatrics and Health News

Childhood Acute Kidney Injury In ICU Raises Risk Of Chronic Kidney Disease http://t.co/VQQoqRbN #pediatrics

1 week ago...

Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis

drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com

Most Recently Shared on March 27, 2012 at 11:41 pm By:

Drugs.com Health Site

FDA Approves Omontys (peginesatide) for the Treatment of Anemia Due to Chronic Kidney Disease - http://t.co/rluIf9fp

Drugs and Devices OW OW Health

Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis

drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com

Most Recently Shared on March 27, 2012 at 11:06 pm By:

Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia D... http://t.co/O4BqcAm5 #drug

Luke Timmerman Health Communicator

Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis - Yahoo! Finance

finance.yahoo.com — “From Yahoo! Finance: Affymax, Inc. and Takeda Pharmaceutical Company Limited , today announced that the U.S. Food and Drug Administration approved OMONTYS® Injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.” View full resource at finance.yahoo.com

Most Recently Shared on March 27, 2012 at 6:44 pm By:

Affymax conf call coming up fast, 2:45 pm ET/11:45 am PT. http://t.co/8TpSAOyY

PhysOrg Health News Health News

Long-term outcomes of TAVI show non-cardiac co-morbidities main cause of mortality

medicalxpress.com — “Non-cardiac co-morbidities such as chronic obstructive pulmonary disease, chronic kidney disease and frailty are the main predictors of late mortality after transcatheter aortic valve implantation (TAVI), suggesting that patients with these conditions merit closer evaluation and follow-up, according ...” View full resource at medicalxpress.com

Most Recently Shared on March 26, 2012 at 1:07 pm By:

Long-term outcomes of TAVI show non-cardiac co-morbidities main cause of mortality http://t.co/0mZaeNtY

Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency | LinkedIn

events.linkedin.com — “PROGRAM OVERVIEW Statins dramatically reduce cardiovascular risk by lowering LDL-C levels, however, their use in some patients requires additional considerations, such as those with chronic kidney disease. In addition, there are significant safety and efficacy differences within the class that must be understood to ensure patients receive the optimal therapy and cardioprotective benefits of the class of drugs. Newer statins can achieve more pronounced LDL-C reductions at lower dosages, reducing ” View full resource at events.linkedin.com

Most Recently Shared on March 25, 2012 at 3:44 pm By:

James Underberg Physician, Doctor, and Internist

LinkedIn Events: Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency http://t.co/HLehljFL

High Blood Glucose Increases CKD Chances in Elderly

renalbusiness.com — “CHEVY CHASE, Md.—According to a recent study in the Journal of Clinical Endocrinology and Metabolism (JCEM), elderly people with the metabolic syndrome defined as having multiple risk factors associated with developing diabetes and heart disease, had an increased risk of chronic kidney disease.” View full resource at renalbusiness.com

Most Recently Shared on March 23, 2012 at 8:14 pm By:

KMorales Nurse

High Blood Glucose Increases CKD Chances in Elderly http://t.co/mu6MDwLL

Obesity Does Not Affect CKD Progression Rate - Renal and Urology News

renalandurologynews.com — “Although obesity is known to increase a person's risk of developing chronic kidney disease (CKD), it has no effect on CKD progression, a study found.” View full resource at renalandurologynews.com

Most Recently Shared on March 22, 2012 at 10:02 pm By:

Renal Urology News Medical Publisher, Health News, Nephrology, and Urology

Obesity Does Not Affect CKD Progression Rate. http://t.co/R8QwgAIf #Kidney #News #HCsm

Health IT company uses software to help manage chronic kidney disease

medcitynews.com — “Read how a new health IT software helps manage dosing of erythropoiesis-stimulation agents for anemia in patients with chronic kidney disease.” View full resource at medcitynews.com

Most Recently Shared on March 22, 2012 at 6:27 pm By:

Kent Bottles, MD Doctor, Pathologist, and Physician

Health IT company uses software to help manage chronic kidney disease http://t.co/HsJAJZGH

MedWire News - General Practice - GPs urged to inform patients of CKD

medwire-news.md — “MedWire News GPs should be more open to informing patients that they have chronic kidney disease, in order to optimise their management and avoid missed opportunities to prevent disease progression, say experts. MedWire News” View full resource at medwire-news.md

Most Recently Shared on March 22, 2012 at 4:50 pm By:

MedWire News Health News

GPs urged to inform patients of CKD http://t.co/KdHEKrdS

ACP: HospitalistWeekly - 21 March 2012

acphospitalist.org — “ACP: HospitalistWeekly - 21 March 2012” View full resource at acphospitalist.org

Most Recently Shared on March 21, 2012 at 11:00 am By:

ACP Medical Society

Association of race questioned in differences with bleeds during reperfusion http://t.co/pMyvqzny ACP HospitalistWeekly article

Stage 2 of Chronic Kidney Disease - DaVita

davita.com — “The NKF has divided chronic kidney disease into five stages to help those who have renal disease know when they are at end stage renal failure and need dialysis. Learn more about stage 2 of CKD.” View full resource at davita.com

Most Recently Shared on March 21, 2012 at 12:25 am By:

UKRO Nephrology and Research

@beautiful_pa200 Stg 2 is classified mild CKD; there are things u can do 2 stop CKD progress or at least slow it down. http://t.co/9HlEUbrD

Dr Michael Banks - The Doctor's Channel Health Site

Antiplatelet therapy benefit doubtful in chronic kidney disease - The Doctor's Channel

thedoctorschannel.com — “NEW YORK (Reuters Health) – Results of a meta-analysis indicate that patients with chronic kidney disease (CKD) derive little net benefit from antiplatelet therapy in terms of cardiovascular outcomes but may be put at increased risk for bleeding complications, according to a...” View full resource at thedoctorschannel.com

Most Recently Shared on March 20, 2012 at 10:15 pm By:

Will your CKS patients benefit from Antiplatelet therapy? -From Reuters Health/TDC #Nephrology #chronickidneydisease http://t.co/EictaF3e

4 weeks ago...